IMARC Group, a leading market research company, has recently releases report titled “Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global antifungal drugs market share, size, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the antifungal drugs market?
The global antifungal drugs market size reached US$ 14.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.
Market Outlook:
Antifungal Drugs are pharmaceutical agents used to treat fungal infections caused by various types of fungi, including yeasts and molds. Antifungal drugs can be fungistatic, inhibiting the growth and replication of fungi, or fungicidal, directly killing the fungal cells, thereby eliminating the infection. Fungal infections can affect different parts of the body, including the skin, nails, respiratory system, and internal organs. The drugs play a crucial role in combating these infections and restoring health to individuals. Antifungal drugs can be administered orally, intravenously, or applied topically, depending on the type and severity of the fungal infection and their efficacy varies depending on the type of fungus, the site of infection, and individual patient factors. Antifungal drugs may be used in combination with other medications or therapies to enhance efficacy, especially in severe or resistant fungal infections.
Request Free Report Sample: https://www.imarcgroup.com/antifungal-drugs-market/requestsample
Market Trends:
The global market is primarily driven by the increasing prevalence of fungal infections, such as candidiasis, aspergillosis, and dermatophytosis. This can be attributed to various factors such as immunosuppression, aging population, and the spread of drug-resistant strains. In line with this, the availability of rapid diagnostic tests, such as PCR and antigen detection assays, is facilitating targeted therapy and hence driving the demand for antifungal drugs.
Moreover, the rapid expansion of healthcare infrastructure, particularly in developing regions, is resulting in enhanced access to healthcare services, including antifungal treatment, which is fueling the market. Furthermore, considerable rise in immunocompromised patient population, such as organ transplant recipients, cancer patients undergoing chemotherapy, and those with HIV/AIDS that is highly susceptible to fungal infections is propelling the demand for antifungal drugs to manage and prevent infections.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Arcadia Consumer Healthcare Inc.
- Astellas Pharma Inc.
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Scynexis Inc.
Explore Full Report Description At: https://www.imarcgroup.com/antifungal-drugs-market
Key Market Segmentation:
The report has segmented the global antifungal drugs market on the basis of drug class, indication and region.
Breakup by Drug Class:
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
Breakup by Indication:
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group
